These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 10500898)

  • 1. Treatment of the hypertensive patient with microvascular angina.
    Ventura H; Loyalka P; Smart FW
    Curr Opin Cardiol; 1999 Sep; 14(5):370-4. PubMed ID: 10500898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hypertensive microangiopathy].
    Skarke C; Stellwaag M
    Dtsch Med Wochenschr; 2000 Apr; 125 Suppl 1():S14-5. PubMed ID: 10819000
    [No Abstract]   [Full Text] [Related]  

  • 3. Recent developments in microvascular angina.
    Ali O; Smart FW; Nguyen T; Ventura H
    Curr Atheroscler Rep; 2001 Mar; 3(2):149-55. PubMed ID: 11177659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Management of hypertensive patients with cardiovascular damage].
    Tomiyama H; Takata Y; Yamashina A
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():612-6. PubMed ID: 15171444
    [No Abstract]   [Full Text] [Related]  

  • 5. Three-year follow-up of the Japanese patients with microvascular angina attributable to coronary microvascular spasm.
    Masumoto A; Mohri M; Takeshita A
    Int J Cardiol; 2001 Dec; 81(2-3):151-6. PubMed ID: 11744131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Dipyridamole-echocardiography and thallium exercise myocardial scintigraphy in the diagnosis of obstructive coronary or microvascular disease in hypertensive patients with left ventricular hypertrophy and angina].
    Astarita C; Nicolai E; Liguori E; Gambardella S; Rumolo S; Maresca FS
    G Ital Cardiol; 1998 Sep; 28(9):996-1004. PubMed ID: 9788038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microvascular angina in systemic hypertension: diagnosis and treatment with enalapril.
    Iriarte MM; Caso R; Murga N; López de Argumedo M; Sagastagoitia D
    Am J Cardiol; 1995 Nov; 76(13):31D-34D. PubMed ID: 7495215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current perspective on the use of calcium channel blockers to treat hypertensive patients: the role of lercanidipine.
    Mancia G; Tsioufis K
    Future Cardiol; 2019 Jul; 15(4):259-266. PubMed ID: 31180724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac effects of combination therapy in hypertension.
    Messerli FH; Chander K
    J Cardiovasc Pharmacol; 2000; 35 Suppl 3():S17-22. PubMed ID: 10854047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dihydropyridines versus other agents in the treatment of hypertension in the elderly. Part 1: Antihypertensive therapy and left ventricular hypertrophy.
    Fagard R; Staessen J; Thijs L; Van Hoof R; Amery A
    J Hypertens Suppl; 1993 Dec; 11(6):S27-9. PubMed ID: 7909547
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of changes in blood pressure and left ventricular mass induced by antihypertensive treatment on ventricular arrhythmias in essential hypertension.
    Muiesan ML; Zulli R; Rizzoni D; Calebich S; Malerba M; Porteri E; Agabiti-Rosei E
    J Hypertens Suppl; 1993 Dec; 11(5):S104-5. PubMed ID: 8158296
    [No Abstract]   [Full Text] [Related]  

  • 12. [Therapy for hypertension associated with heart failure].
    Miyamoto H; Imaizumi T
    Nihon Naika Gakkai Zasshi; 2003 Feb; 92(2):258-63. PubMed ID: 12652730
    [No Abstract]   [Full Text] [Related]  

  • 13. Determinants of left ventricular mass reduction in essential hypertension.
    Grodzicki T; Messerli FH; Soria F; Aristizabal D; Frohlich ED
    J Hypertens Suppl; 1993 Dec; 11(5):S364-5. PubMed ID: 8158424
    [No Abstract]   [Full Text] [Related]  

  • 14. Presence of cardiovascular structural changes in essential hypertensive patients with coronary microvascular disease and effects of long-term treatment.
    Virdis A; Ghiadoni L; Lucarini A; Di Legge V; Taddei S; Salvetti A
    Am J Hypertens; 1996 Apr; 9(4 Pt 1):361-9. PubMed ID: 8722438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on reversal of left ventricular hypertrophy in essential hypertension (a meta-analysis of all randomized double-blind studies until December 1996).
    Schmieder RE; Schlaich MP; Klingbeil AU; Martus P
    Nephrol Dial Transplant; 1998 Mar; 13(3):564-9. PubMed ID: 9550628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversal of left ventricular hypertrophy in essential hypertension. A meta-analysis of randomized double-blind studies.
    Schmieder RE; Martus P; Klingbeil A
    JAMA; 1996 May; 275(19):1507-13. PubMed ID: 8622227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of left ventricular hypertrophy in hypertensive patients with a combination of verapamil and captopril--a multicenter study.
    Magometschnigg D; Brandt D; Hofmann R; Sihorsch K; Stoschitzky K; Zangeneh M; Zenker G
    Int J Clin Pharmacol Ther; 1997 Sep; 35(9):389-96. PubMed ID: 9314093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Syndrome X].
    Matsumoto T; Horie M; Mitsunami K
    Nihon Rinsho; 2007 Sep; Suppl 5 Pt 2():143-6. PubMed ID: 17952986
    [No Abstract]   [Full Text] [Related]  

  • 19. [Microvascular angina].
    Katagiri T; Suzuki H; Takeyama Y
    Nihon Rinsho; 2007 Sep; Suppl 5 Pt 2():223-7. PubMed ID: 17948704
    [No Abstract]   [Full Text] [Related]  

  • 20. A meta-analysis of the effects of treatment on left ventricular mass in essential hypertension.
    Klingbeil AU; Schneider M; Martus P; Messerli FH; Schmieder RE
    Am J Med; 2003 Jul; 115(1):41-6. PubMed ID: 12867233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.